Supplier
Hillcroft Physicians, PA
Hillcroft Physicians, PA was paid $4.35M by Medicaid between Jan 2018 and Dec 2024, across 113 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoHILLCROFT PHYSICIANS, PA
HOUSTON, TX 77081
HOUSTON, TX 77081
33aNPI1427108182assigned 01/12/2007
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$4.35M
24GClaims306,631
24DCodes billed113
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Texas
Rank by total paid#43 of 566
Median peer was paid$142K
This provider vs. median31×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,502 | $188K | |
| 2019 | 1,967 | $24K | |
| 2020 | 15,708 | $207K | |
| 2021 | 61,071 | $814K | |
| 2022 | 78,128 | $1.19M | |
| 2023 | 67,085 | $963K | |
| 2024incomplete | 73,170 | $966K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 45,563 | 38,105 | $1.62M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 14,631 | 12,729 | $681K |
| 87428 | 9.8% | 9,103 | 8,582 | $426K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.6% | 14,524 | 13,781 | $199K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.3% | 2,218 | 2,166 | $188K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.7% | 1,721 | 1,686 | $159K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.7% | 3,662 | 3,458 | $159K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.4% | 10,865 | 5,220 | $148K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.2% | 12,388 | 6,414 | $139K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.2% | 1,216 | 1,188 | $97K |
| S8301 | Infection control supplies, not otherwise specified | 1.7% | 19,430 | 16,120 | $72K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.4% | 901 | 874 | $63K |
101 more codes
| 99203 | Doctor's office visit, new patient (routine) | 1.4% | 1,030 | $61K |
| 87634 | <1% | 695 | $40K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,011 | $24K |
| 97802 | <1% | 10,141 | $23K | |
| 93000 | <1% | 1,589 | $18K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 259 | $18K |
| 99429 | <1% | 516 | $18K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,072 | $17K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,510 | $16K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 190 | $16K |
| 81025 | <1% | 2,097 | $15K | |
| H0049 | Alcohol and/or drug screening | <1% | 2,161 | $12K |
| 92552 | <1% | 1,743 | $12K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 456 | $10K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 931 | $10K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 95 | $9K |
| 90461 | <1% | 2,294 | $8K | |
| 81003 | <1% | 3,775 | $7K | |
| 83013 | <1% | 105 | $6K | |
| 82947 | <1% | 2,165 | $6K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 69 | $5K |
| 96160 | <1% | 4,828 | $4K | |
| S8101 | Holding chamber or spacer for use with an inhaler or nebulizer; with mask | <1% | 905 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 397 | $4K |
| 90688 | <1% | 231 | $3K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 38 | $3K |
| 86769 | <1% | 102 | $3K | |
| 99072 | <1% | 13,131 | $3K | |
| 90686 | <1% | 2,059 | $2K | |
| 99490 | Ccm add 20min | <1% | 1,017 | $2K |
| 99383 | <1% | 14 | $1K | |
| 99442 | <1% | 32 | $1K | |
| 87807 | <1% | 84 | $1K | |
| 98960 | <1% | 452 | $1K | |
| 10040 | <1% | 12 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 12 | $1K |
| 99000 | <1% | 117 | $1K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 12 | $944.88 |
| 90661 | <1% | 556 | $664.83 | |
| 83014 | <1% | 105 | $655.58 | |
| 3044F | <1% | 627 | $480.00 | |
| 72100 | <1% | 13 | $362.81 | |
| 97169 | <1% | 76 | $359.40 | |
| 74019 | <1% | 13 | $331.78 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 159 | $324.97 |
| 94010 | <1% | 13 | $292.22 | |
| 99439 | <1% | 24 | $103.48 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 15 | $99.78 |
| 99497 | <1% | 67 | $82.38 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 14 | $72.47 |
| 82044 | <1% | 13 | $54.38 | |
| 82570 | <1% | 13 | $50.22 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 877 | $39.58 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12 | $19.72 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 10,779 | $17.52 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $10.86 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 54,439 | $8.14 |
| 90674 | <1% | 740 | $7.02 | |
| 90651 | <1% | 192 | $0.24 | |
| 3077F | <1% | 86 | $0.01 | |
| 3078F | <1% | 819 | $0.01 | |
| 90650 | 0% | 216 | $0.00 | |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 32 | $0.00 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 0% | 782 | $0.00 |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 1,859 | $0.00 |
| 3074F | 0% | 775 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 1,164 | $0.00 |
| 99606 | 0% | 1,120 | $0.00 | |
| 3079F | 0% | 135 | $0.00 | |
| 3017F | 0% | 27 | $0.00 | |
| 90744 | 0% | 52 | $0.00 | |
| G2058 | Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)). | 0% | 198 | $0.00 |
| 90716 | 0% | 25 | $0.00 | |
| 1123F | 0% | 68 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 292 | $0.00 |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 0% | 12 | $0.00 |
| 90723 | 0% | 43 | $0.00 | |
| 3027F | 0% | 12 | $0.00 | |
| 1036F | 0% | 63 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 30 | $0.00 |
| 3075F | 0% | 12 | $0.00 | |
| 90620 | 0% | 14 | $0.00 | |
| 1159F | 0% | 14,951 | $0.00 | |
| 90685 | 0% | 13 | $0.00 | |
| 3210F | 0% | 14,453 | $0.00 | |
| 99173 | 0% | 4,230 | $0.00 | |
| 90633 | 0% | 432 | $0.00 | |
| 99188 | 0% | 209 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 32 | $0.00 |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 248 | $0.00 |
| 94664 | 0% | 394 | $0.00 | |
| 90734 | 0% | 194 | $0.00 | |
| 90713 | 0% | 39 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 68 | $0.00 |
| 99408 | 0% | 29 | $0.00 | |
| 90670 | 0% | 54 | $0.00 | |
| 90715 | 0% | 30 | $0.00 | |
| 90648 | 0% | 52 | $0.00 | |
| 3023F | 0% | 12 | $0.00 | |
| 90710 | 0% | 13 | $0.00 | |
| S9470 | Nutritional counseling, dietitian visit | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFARIZANI, FOROUGH (MEDICAL DIRECTOR)